New Belgian Innovation Office To Accelerate Availability of Novel Medicines
Executive Summary
The Belgian medicines agency's innovation office will initially focus on providing support to SMEs and academia developing innovative medicines, and then move on to other tasks, such as providing iterative scientific advice, pre-submission guidance and early-phase regulatory advice to drug sponsors.
You may also be interested in...
New Network To Boost Coordination On Innovative Drugs Across Europe
The newly established EU Innovation Network aims to increase the visibility of the support being offered by national competent authorities to innovative medicinal products in member states, and help boost the delivery of novel medicines to patients.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.